Dergiler / The European Research Journal / 2019 / Cilt: 5 - Sayı: 5

Effect of urinary excretion on radiation dose in patients having PET/CT scans

Sayfa
722–728
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusions: Active emptying of bladder in patients having PET/CT scans where 18F-FDG radiopharmaceutical is involved is an effective method for the radiation safety of both health workers and patients.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: 18Fluorine-fluorodeoxyglucose (18F-FDG) positron emission tomography/ computed tomography (PET/CT) is commonly used for diagnosis, staging and re-staging of cancers and for determining the effectiveness of treatment.
📊
Temel Bulgular & Veri:Because of renal, ureteral and urinary involvement of 18F-FDG radiopharmaceutical after its injection, patients subject to radioactivity during its effective half-life.
💡
Sonuç & Katkı:Conclusions: Active emptying of bladder in patients having PET/CT scans where 18F-FDG radiopharmaceutical is involved is an effective method for the radiation safety of both health workers and patients.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:18Fluorine-fluorodeoxyglucose · positron emission tomography · computed tomography

Abstract

Objectives: 18Fluorine-fluorodeoxyglucose (18F-FDG) positron emission tomography/ computed tomography (PET/CT) is commonly used for diagnosis, staging and re-staging of cancers and for determining the effectiveness of treatment. Because of renal, ureteral and urinary involvement of 18F-FDG radiopharmaceutical after its injection, patients subject to radioactivity during its effective half-life. The aim of the present study was to determine the degree of association between effective dose levels of patients and bladder emptying of patients having PET/CT scans. Methods: The present retrospective study included 108 patients (43 females and 65 males, average age: 60.9 ± 12.7 years). Effective dose level as mSv/h was determined from a distance of 1 m in all patients before and after bladder emptying at the first hour following 18F-FDG injection. Radioactivity excretion amounts were compared based on gender, age, body mass index, fasting blood sugar level and clinical diagnosis. Results: Amount of radioactivity decreased by 22.75% ± 14.77% after bladder emptying. No association was found between urinary excretion level and age, gender, fasting blood sugar and body mass index (p > 0.05). Conclusions: Active emptying of bladder in patients having PET/CT scans where 18F-FDG radiopharmaceutical is involved is an effective method for the radiation safety of both health workers and patients.

🔖

Bu Makaleye Atıf Yap

GÜL, S. S., ESEN, M. (2019). Effect of urinary excretion on radiation dose in patients having PET/CT scans. The European Research Journal, Cilt: 5 - Sayı: 5, 722–728. https://ajindex.com/articles/361089

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Siegel JA, Stabin MG. Medical imaging: the challenges of radiation risk assessment. J Nucl Med 2014;55:16-7
  2. Grigsby PW. The prognostic value of PET and PET/CT in cervical cancer. Cancer Imaging 2008;8:146-55
  3. Anderson C, Koshy M, Staley C, Esiashvili N, Ghavidel S, Fowler Z, et al. PET-CT fusion in radiation management of patients with anorectal tumors. Int J Radiat Oncol Biol Phys 2007;69:155-62
  4. Jha AK, Zade A, Rangarajan V. Estimation of radiation dose received by the radiation worker during F-18 FDG injection process. Indian J Nucl Med 2011;26:11-3
  5. Hasbek Z, Doğan ÖT, Sarı İ, Yücel B, Şeker MM, Turgut B, et al. The diagnostic value of the correlation between serum anti-p53 antibody and positron emission tomography parameters in lung cancer. Mol Imaging Radionucl Ther 2016;25:107-13
  6. Delgado Bolton RC, MucientesRasilla J, Perez Castejon MJ, Carreras Delgado JL. [Positron emission tomography (PET) and PET-CT in renal, bladder and prostate cancer: update]. Actas Urol Esp 2009;33:11-23. [Article in Spanish] [7] Hoilund-Carlsen PF, Poulsen MH, Petersen H, Hess S, Lund L. FDG in urologic malignancies. PET Clin 2014;9:457-68
  7. Khiewvan B, Torigian DA, Emamzadehfard S, Paydary K, Salavati A, Houshmand S, et al. Update of the role of PET/CT and PET/MRI in the management of patients with cervical cancer. Hell J Nucl Med 2016;19:254-68
  8. Do KH. General principles of radiation protection in fields of diagnostic medical exposure. J Korean Med Sci. 2016;31:6-9
  9. Börksüz MF, Erselcan T, Hasbek Z, Yücel B, Turgut B. Morphologic and metabolic comparison of treatment responsiveness with 18fludeoxyglucose-positron emission tomography/ computed tomography according to lung cancer type. Mol Imaging Radionucl Ther 2016;25:63-9
  10. Shyn PB. Interventional positron emission tomography/computed tomography: state-of-the-art. Tech Vasc Interv Radiol 2013;6:182-90
  11. Hasbek Z, Yucel B, Salk I, Turgut B, Erselcan T, Babacan NA, et al. Potential impact of atelectasis and primary tumor glycolysis on F-18 FDG PET/CT on survival in lung cancer patients. Asian Pac J Cancer Prev 2014;15:4085-9
  12. Anjos DA, Etchebehere EC, Ramos CD, Santos AO, Albertotti C, Camargo EE. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer. J Nucl Med 2007;48:764-70
  13. Gorospe L, Jover-Diaz R, Vicente-Bartulos A. Spectrum of PET-CT pelvic pitfalls in patients with gynecologic malignancies. Abdom Imaging 2012;37:1041-65
  14. Yildi